Table 5.
Multivariate analysis of clinicopathological variables associated with relapse-free survival in the non-molecular apocrine TNBC subgroup.
| Relapse-Free Survival (n = 134) | |||
|---|---|---|---|
| HR | p | 95% CI | |
| Lymph node status | |||
| N- | 1 | ||
| N+ | 2.62 | 0.009 | 1.27 - 5.39 |
| TIGIT* | |||
| Low | 1 | ||
| High | 0.41 | 0.025 | 0.19 - 0.89 |
| PVR § | |||
| Low | 1 | ||
| High | 0.39 | 0.032 | 0.16 - 0.92 |
| PD-L1 (tumor cells) | |||
| <1% | 1 | ||
| ≥1% | 0.51 | 0.092 | 0.23 - 1.11 |
Low and high categories were defined according to the median*, and for PVR by grouping the two first terciles versus the third§ (see Material and Methods).